Skip to main content
$73.31 $3.04 (4.3%)

04:00 PM EST on 01/30/23

Axsome Therapeutics, Inc. (NASDAQ:AXSM)

CAPS Rating: 2 out of 5

Current Price $73.31 Mkt Cap $3.1B
Open $71.35 P/E Ratio 0.00
Prev. Close $73.31 Div. (Yield) $0.00 (0.0%)
Daily Range $71.07 - $74.16 Volume 931,792
52-Wk Range $20.63 - $82.00 Avg. Daily Vol. 971,062

Caps

How do you think NASDAQ:AXSM will perform against the market?

Add Stock to CAPS Watchlist

All Players

72 Outperform
16 Underperform
 

All-Star Players

9 Outperform
13 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:AXSM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFAdriaCimino (< 20)
Submitted September 13, 2022

Axsome just acquired a drug for sleep disorders -- and that drug saw triple-digit sales growth last year. And Axsome just won FDA approval for a drug for major depressive disorder. This is expected to become a blockbuster. These are two key growth… More

TMFBiologyFool (70.74)
Submitted April 03, 2020

CNS diseases with patient-reported outcomes are so difficult to show efficacy.

NASDAQ:AXSM Summary

Fools bullish on NASDAQ:AXSM are also bullish on:

Fools bearish on NASDAQ:AXSM are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AXSM.

Recs

1
Member Avatar TMFAdriaCimino (< 20) Submitted: 9/13/2022 2:40:57 PM : Outperform Start Price: $60.23 NASDAQ:AXSM Score: +20.63

Axsome just acquired a drug for sleep disorders -- and that drug saw triple-digit sales growth last year. And Axsome just won FDA approval for a drug for major depressive disorder. This is expected to become a blockbuster. These are two key growth drivers that are at the beginning of their story.

Recs

1
Member Avatar TMFjimhalley (< 20) Submitted: 5/12/2022 1:07:26 PM : Outperform Start Price: $24.94 NASDAQ:AXSM Score: +191.33

The company should benefit from revenue from Sunosi, as well as AXS-05, when that drug is approved.

Recs

1
Member Avatar folge (< 20) Submitted: 5/2/2022 3:54:45 PM : Outperform Start Price: $34.10 NASDAQ:AXSM Score: +118.29

They're about to commercialize the world's next blockbuster drug - AXS-05 - and have many others with positive testing results.

Leaderboard

Find the members with the highest scoring picks in AXSM.

Score Leader

jeepdrew222

jeepdrew222 (61.04) Score: +2,680.89

The Score Leader is the player with the highest score across all their picks in AXSM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
jeepdrew222 61.04 8/27/2018 Outperform 5Y $2.60 +2,719.62% +38.72% +2,680.89 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Under5 65.28 2/9/2018 5/25/2022 Outperform 5Y $2.60 +2,719.62% +53.65% +2,665.97 0 Comment
NextGenStock < 20 6/20/2018 Outperform 5Y $3.00 +2,343.67% +45.05% +2,298.62 0 Comment
NateVDM214 < 20 6/21/2018 Outperform 3Y $3.15 +2,227.30% +45.21% +2,182.09 0 Comment
jumbofaceplate 21.27 5/15/2017 Outperform 5Y $4.10 +1,688.05% +67.34% +1,620.71 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. ababrmon 60.73 1/2/2018 Outperform 5Y $5.47 +1,240.51% +49.36% +1,191.16 0 Comment
warmwind < 20 1/13/2017 Outperform 5Y $5.50 +1,232.91% +76.74% +1,156.17 0 Comment
clangmead 47.53 1/15/2019 Outperform 5Y $7.52 +874.87% +55.43% +819.44 0 Comment
Momentum21 85.11 6/2/2016 Outperform 5Y $7.68 +854.56% +90.59% +763.97 0 Comment
Reallynow222 91.90 2/28/2019 Outperform 5Y $8.20 +794.02% +43.51% +750.52 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AXSM.